A nurse is preparing to administer clindamycin 900 mg by intermittent IV bolus over 30 min. Available is clindamycin 900 mg in 100 mL dextrose 5% (D5W). The nurse should set the IV pump to deliver how many mL/hr?

(Round the answer to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero)

Choice A reason: Preeclampsia is not the correct answer, as it is a hypertensive disorder of pregnancy that causes high blood pressure, proteinuria, and edema. Preeclampsia can be a risk factor for abruptio placentae, which is a premature separation of the placenta from the uterine wall, but it is not a complication of it. Preeclampsia does not cause petechiae or bleeding around the IV access site, but rather headaches, blurred vision, or epigastric pain.

Choice B reason: Anaphylactoid syndrome of pregnancy is not the correct answer, as it is a rare and fatal condition that occurs when the amniotic fluid enters the maternal circulation and causes an allergic reaction. Anaphylactoid syndrome of pregnancy can occur as a complication of abruptio placentae, but it is not indicated by the petechiae or bleeding around the IV access site. Anaphylactoid syndrome of pregnancy would cause respiratory distress, hypotension, or cardiac arrest.

Choice C reason: Puerperal infection is not the correct answer, as it is a bacterial infection of the reproductive tract that occurs after childbirth. Puerperal infection can occur as a complication of abruptio placentae, but it is not indicated by the petechiae or bleeding around the IV access site. Puerperal infection would cause fever, foul-smelling lochia, or pelvic pain.

Choice D reason: Disseminated intravascular coagulation is the correct answer, as it is a coagulation disorder that causes widespread clotting and bleeding in the body. Disseminated intravascular coagulation can occur as a complication of abruptio placentae, and it is indicated by the petechiae and bleeding around the IV access site. Disseminated intravascular coagulation would also cause a low platelet count, a prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), and a low fibrinogen level.

Choice A reason: Misoprostol is not the first line medication for postpartum hemorrhage, as it is a prostaglandin E1 analog that causes uterine contractions and cervical ripening. Misoprostol is used for the prevention and treatment of postpartum hemorrhage, but it is less effective and more side effects than oxytocin, which is the first line medication.

Choice B reason: Pitocin is the first line medication for postpartum hemorrhage, as it is a synthetic form of oxytocin, which is a hormone that stimulates uterine contractions and retraction. Pitocin is used for the induction and augmentation of labor, and the prevention and treatment of postpartum hemorrhage, as it reduces blood loss and enhances hemostasis.

Choice C reason: Hemabate is not the first line medication for postpartum hemorrhage, as it is a prostaglandin F2 alpha analog that causes uterine contractions and vasoconstriction. Hemabate is used for the treatment of postpartum hemorrhage, but it is contraindicated in clients with asthma, hypertension, or cardiac disease, as it can cause bronchospasm, hypertension, or cardiac arrhythmias.

Choice D reason: Methergine is not the first line medication for postpartum hemorrhage, as it is an ergot alkaloid that causes sustained uterine contractions and vasoconstriction. Methergine is used for the treatment of postpartum hemorrhage, but it is contraindicated in clients with hypertension, preeclampsia, or cardiac disease, as it can cause severe hypertension, cerebrovascular accidents, or myocardial infarction.